Concepedia

Publication | Closed Access

Cardiac mortality in users of olmesartan, other angiotensin‐receptor blockers and angiotensin‐converting enzyme inhibitors

13

Citations

5

References

2013

Year

Abstract

The results of this well-powered study do not raise concerns for the risk of SCD or death from all causes among olmesartan users in comparison with users of other ARBs or ACE inhibitors.

References

YearCitations

Page 1